Luye Pharma Group Stock Price Prediction

LYPHF Stock  USD 0.34  0.00  0.00%   
As of 8th of January 2025 The relative strength index (RSI) of Luye Pharma's share price is above 80 . This indicates that the pink sheet is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

100

 
Oversold
 
Overbought
The successful prediction of Luye Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Luye Pharma and does not consider all of the tangible or intangible factors available from Luye Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Luye Pharma Group, which may create opportunities for some arbitrage if properly timed.
Using Luye Pharma hype-based prediction, you can estimate the value of Luye Pharma Group from the perspective of Luye Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Luye Pharma to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Luye because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Luye Pharma after-hype prediction price

    
  USD 0.34  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Luye Pharma Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.010.281.51
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Luye Pharma. Your research has to be compared to or analyzed against Luye Pharma's peers to derive any actionable benefits. When done correctly, Luye Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Luye Pharma Group.

Luye Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Luye Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Luye Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Luye Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Luye Pharma Estimiated After-Hype Price Volatility

In the context of predicting Luye Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Luye Pharma's historical news coverage. Luye Pharma's after-hype downside and upside margins for the prediction period are 0.02 and 1.57, respectively. We have considered Luye Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.34
0.34
After-hype Price
1.57
Upside
Luye Pharma is extremely dangerous at this time. Analysis and calculation of next after-hype price of Luye Pharma Group is based on 3 months time horizon.

Luye Pharma Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Luye Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Luye Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Luye Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.16 
1.24
 0.00  
  0.05 
0 Events / Month
4 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.34
0.34
0.00 
0.00  
Notes

Luye Pharma Hype Timeline

Luye Pharma Group is now traded for 0.34. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.05. Luye is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.16%. %. The volatility of related hype on Luye Pharma is about 379.2%, with the expected price after the next announcement by competition of 0.39. About 35.0% of the company outstanding shares are owned by corporate insiders. The book value of Luye Pharma was now reported as 2.54. The company last dividend was issued on the 29th of June 2020. Assuming the 90 days horizon the next forecasted press release will be uncertain.
Check out Luye Pharma Basic Forecasting Models to cross-verify your projections.

Luye Pharma Related Hype Analysis

Having access to credible news sources related to Luye Pharma's direct competition is more important than ever and may enhance your ability to predict Luye Pharma's future price movements. Getting to know how Luye Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Luye Pharma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AMGNAmgen Inc 1.55 10 per month 0.00 (0.21) 1.60 (2.70) 9.43 
BMYBristol Myers Squibb 0.48 4 per month 1.40  0.05  2.51 (2.54) 14.38 
RHHVFRoche Holding AG 0.00 0 per month 0.00 (0.12) 2.06 (2.46) 5.80 
NVSEFNovartis AG 0.00 0 per month 0.00 (0.11) 4.12 (4.25) 12.02 
SCLXWScilex Holding(0.03)4 per month 13.16  0.1  36.36 (25.53) 109.99 
RHHBYRoche Holding Ltd 0.00 0 per month 0.00 (0.17) 1.20 (2.28) 5.51 
NVSNovartis AG ADR 0.59 11 per month 0.00 (0.26) 1.36 (2.29) 6.05 
SCLXScilex Holding(0.02)8 per month 0.00 (0.1) 9.38 (10.29) 32.78 
AZNAstraZeneca PLC ADR(0.54)8 per month 0.00 (0.18) 1.51 (3.18) 8.50 
GILDGilead Sciences 1.24 10 per month 1.35  0.07  1.94 (2.23) 10.79 

Luye Pharma Additional Predictive Modules

Most predictive techniques to examine Luye price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Luye using various technical indicators. When you analyze Luye charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Luye Pharma Predictive Indicators

The successful prediction of Luye Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Luye Pharma Group, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Luye Pharma based on analysis of Luye Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Luye Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Luye Pharma's related companies.

Story Coverage note for Luye Pharma

The number of cover stories for Luye Pharma depends on current market conditions and Luye Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Luye Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Luye Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Luye Pharma Short Properties

Luye Pharma's future price predictability will typically decrease when Luye Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Luye Pharma Group often depends not only on the future outlook of the potential Luye Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Luye Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.5 B

Complementary Tools for Luye Pink Sheet analysis

When running Luye Pharma's price analysis, check to measure Luye Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Luye Pharma is operating at the current time. Most of Luye Pharma's value examination focuses on studying past and present price action to predict the probability of Luye Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Luye Pharma's price. Additionally, you may evaluate how the addition of Luye Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk